Healthcare Services company Metropolis Healthcare announced Q2FY26 results Revenue: Rs 429 crore for Q2FY26, change 23% YoY. EBITDA: Rs 109 crore for Q2FY26, change 19% YoY. PAT: Rs 53 crore for Q2FY26, change 13% YoY. Ameera Shah, Promoter & Executive Chairperson, Metropolis Healthcare, said: “We've demonstrated that consistent growth and quality can go hand in hand. The swift turnaround of Core Diagnostics and the strong performance of our recent acquisitions in Dehradun and Agra reaffirm the strength of our integration strategy and our ability to create sustainable value through local excellence. As we advance genomics and AI-enabled innovation alongside digital transformation, we’re driving rapid adoption that expands access to quality diagnostics and accelerates the sector’s shift from unorganised to organised players. Our focus remains on shaping a future-ready Metropolis — a trusted, science-led organisation that sets new benchmarks for quality, care, and value creation.” Surendran Chemmenkotil, Managing Director, Metropolis Healthcare, said: "We delivered consistent results this quarter, in line with our guidance, even as lower incidence of vector-borne diseases impacted seasonal demand. Our focus on execution excellence, productivity enhancement, and operational optimisation helped sustain growth momentum and deliver YoY margin expansion in H1. We continue to deepen our presence across the 750+ towns we serve, with sharper penetration in Tier 2 and Tier 3 markets, supported by a strong product portfolio and productivity-enhancing initiatives in the network. We remain confident of achieving our stated growth and profitability targets for the rest of the year." Result PDF